Cell MedX Corp. is a research and development company focused on pioneering diabetes research and therapeutic product development. The company aims to discover, design, develop, manufacture, and commercialize clinical therapeutic and wellness products that empower individuals to manage their health and general wellness. A key product, the eBalance®, utilizes microcurrent therapeutic technology to aid in disease management, particularly for diabetes and related complications.
Publicly traded on the OTC Markets under the symbol CMXC, Cell MedX has made significant strides in the field of diabetes treatment. The company's innovative approach and commitment to health management have positioned it as a notable player in the therapeutic product market. Through its advanced technologies, Cell MedX continues to impact patient care by providing effective tools for managing chronic illnesses.
